Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients

Neurologia i Neurochirurgia Polska

Volumn 48, Issue 4, 2014, Pages 258-261

  Malec Litwinowicz, Michalina ^a   Rudzińska, Monika ^a,b   Szubiga, Michał ^c   Michalski, Michał ^a   Tomaszewski, Tomasz ^a   Szczudlik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Glucocerebrosidase; Parkinson disease; Parkinson's disease dementia

Indexed keywords

GLUCOSYLCERAMIDASE;

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DNA POLYMORPHISM; DNA SEQUENCE; EXON; FEMALE; GENE; GENE MUTATION; GENETIC RISK; GENETIC VARIABILITY; GLUCOSYLCERAMIDASE GENE; HAMILTON SCALE; HETEROZYGOTE; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; ONSET AGE; PARKINSON DISEASE; UNIFIED PARKINSON DISEASE RATING SCALE;

GLUCOCEREBROSIDASE; PARKINSON DISEASE; PARKINSON'S DISEASE DEMENTIA;

AGED; COGNITION DISORDERS; FEMALE; GLUCOSYLCERAMIDASE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PHENOTYPE; POINT MUTATION; POLAND; RISK FACTORS;

EID: 84906816398     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.1016/j.pjnns.2014.07.005     Document Type: Article

References (10)

1. Slawek J, Derejko M. Depression and dementia: the most frequent non-motor symptoms of Parkinson disease. Neurol Neurochir Pol 2003;37(Suppl. 5):103-15.
2. Sidransky E, Nalls MA, Aasly JO. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009;361:1651-61.
3. Alcalay RN, Mejia-Santana H, Tang MX. Self-report of cognitive impairment and Mini-Mental State Exam performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. Clin Exp Neuropsychol 2010;32:775-9.
4. Alcalay RN, Caccappolo E. Cognitive performance of GBA mutation carriers with early-onset PD. The CORE-PD study. Neurology 2012;78:1434-40.
5. Brockmann K, Srulijes K, Hauser A-K. GBA-associated PD presents with non-motor characteristics. Neurology 2011;77:276-80.
6. Salvia NS, Pagonabarraga J, Houlden H. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course. Mov Disord 2012;27:393-9.
7. Neumann J, Bras J, Deas E. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009;132:1783-94.
8. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-86.
9. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529-30.
10. Hruska KS, Goker-Alpan O, Sidransky E. Gaucher disease and the synucleinopathies. J Biomed Biotechnol 2006;2006:1-6.